TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Routine Sampling Of Breast Duct Cells For Detection Of Cancer Precursors Possible With Ductal Lavage System July 28, 2000
